Taken together, these in vitro studies of in vitro PD-1/PD-L1 blockade using PBMC from TB patients are consistent with increased IFN-γ production observed in Mtb-infected PD-1−/− mice (34, 35). The gene discussed is PDCD1; the disease is tuberculosis.